Effects of duloxetine treatment on brain response to painful stimulation in major depressive disorder

Neuropsychopharmacology

Volumn 35, Issue 11, 2010, Pages 2305-2317

  López Solà, Marina ^a,b   Pujol, Jesus ^a,c   Hernández Ribas, Rosa ^a,d,e   Harrison, Ben J ^a,f   Contreras Rodríguez, Oren ^a,g   Soriano Mas, Carles ^a,g   Deus, Joan ^a,h   Ortiz, Héctor ^a   Menchón, José M ^d,e   Vallejo, Julio ^b,e   Cardoner, Narcís ^a,d,e  

^a HOSPITAL DEL MAR   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

^d HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^e CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

^f UNIVERSITY OF MELBOURNE   (Australia)

^g Barcelona Biomedical Research Park   (Spain)

^h UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

brain; duloxetine; fMRI; major depressive disorder; pain; treatment

Indexed keywords

DULOXETINE;

ADULT; ANTERIOR CINGULATE; ARTICLE; BASAL GANGLION; BRAIN DEPTH STIMULATION; BRAIN REGION; BRAIN STEM RESPONSE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG DOSE INCREASE; DRUG EFFICACY; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; MAJOR DEPRESSION; MALE; PAIN ASSESSMENT; PONS; PONS ANGLE; PREFRONTAL CORTEX; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; SINGLE DRUG DOSE; THERAPY EFFECT; TREATMENT RESPONSE;

ADULT; BRAIN; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PAIN; PAIN MEASUREMENT; THIOPHENES; TREATMENT OUTCOME;

EID: 78651319205     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/npp.2010.108     Document Type: Article

References (96)

1. American Psychiatric Association (2000). Diagnostic and Statistical Manual of Mental Disorders 4th edn. text revision. American Psychiatric Press: Washington, DC.
2. Apkarian AV, Bushnell MC, Treede RD, Zubieta JK (2005). Human brain mechanisms of pain perception and regulation in health and disease. Eur J Pain 9: 463-484.
3. Bär KJ, Brehm S, Boettger MK, Boettger S, Wagner G, Sauer H (2005). Pain perception in major depression depends on pain modality. Pain 117: 97-103.
4. Bär KJ, Brehm S, Boettger MK, Wagner G, Boettger S, Sauer H (2006). Decreased sensitivity to experimental pain in adjustment disorder. Eur J Pain 10: 467-471.
5. Bär KJ, Greiner W, Letsch A, Köbele R, Sauer H (2003). Influence of gender and hemispheric lateralization on heat pain perception in major depression. J Psychiatr Res 37: 345-353.
6. Bär KJ, Wagner G, Koschke M, Boettger S, Boettger MK, Schlösser R et al (2007). Increased prefrontal activation during pain perception in major depression. Biol Psychiatry 62: 1281-1287.
7. Bair MJ, Robinson RL, Katon W, Kroenke K (2003). Depression and pain comorbidity: a literature review. Arch Intern Med 163: 2433-2445.
8. Barbas H, Saha S, Rempel-Clower N, Ghashghaei T (2003). Serial pathways from primate prefrontal cortex to autonomic areas may influence emotional expression. BMC Neurosci 10: 4-25.
9. Blier P, Abbott FV (2001). Putative mechanisms of action of antidepressant drugs in affective and anxiety disorders and pain. J Psychiatry Neurosci 26: 37-43.
10. Brockmann H, Zobel A, Joe A, Biermann K, Scheef L, Schuhmacher A et al (2009). The value of HMPAO SPECT in predicting treatment response to citalopram in patients with major depression. Psychiatry Res 173: 107-112.
11. Chen CH, Ridler K, Suckling J, Williams S, Fu CH, Merlo-Pich E et al (2007). Brain imaging correlates of depressive symptom severity and predictors of symptom improvement after anti-depressant treatment. Biol Psychiatry 62: 407-414.
12. Cleeland CS, Ryan KM (1994). Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singapore 23: 129-138.
13. Davidson RJ (2002). Anxiety and affective style: role of prefrontal cortex and amygdala. Biol Psychiatry 51: 68-80.
14. Davidson RJ, Irwin W, Anderle MJ, Kalin NH (2003). The neural substrates of affective processing in depressed patients treated with venlafaxine. Am J Psychiatry 160: 64-75.
15. Davidson RJ, Pizzagalli D, Nitschke JB, Putnam K (2002). Depression: perspectives from affective neuroscience. Annu Rev Psychol 53: 545-574.
16. Dickens C, McGowan L, Dale S (2003). Impact of depression on experimental pain perception: a systematic review of the literature with meta-analysis. Psychosom Med 65: 369-375.
17. Dougherty DD, Weiss AP, Cosgrove GR, Alpert NM, Cassem EH, Nierenberg AA et al (2003). Cerebral metabolic correlates as potential predictors of response to anterior cingulo-tomy for treatment of major depression. J Neurosurg 99: 1010-1017.
18. Drevets WC (2000). Neuroimaging studies of mood disorders. Biol Psychiatry 48: 813-829.
19. Drevets WC, Bogers W, Raichle ME (2002). Functional anatomical correlates of antidepressant drug treatment assessed using PET measures of regional glucose metabolism. Eur Neuropsycho-pharmacol 12: 527-544.
20. Drevets WC, Price JL, Furey ML (2008a). Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression. Brain Struct Funct 213: 93-118.
21. Drevets WC, Savitz J, Trimble M (2008b). The subgenual anterior cingulate cortex in mood disorders. CNS Spectr 13: 663-681.
22. First MB, Spitzer RL, Gibbon M, Williams JBW (1997). Structured Clinical Interview for DSM-IV Axis I DisordersF Clinician Version (SCID-CV). American Psychiatric Press: Washington, DC.
23. Frewen PA, Dozois DJ, Lanius RA (2008). Neuroimaging studies of psychological interventions for mood and anxiety disorders: empirical and methodological review. Clin Psychol Rev 28: 228-246.
24. Fu CH, Williams SC, Cleare AJ, Brammer MJ, Walsh ND, Kim J et al (2004). Attenuation of the neural response to sad faces in major depression by antidepressant treatment: a prospective, event-related functional magnetic resonance imaging study. Arch Gen Psychiatry 61: 877-889.
25. Fu CH, Williams SC, Cleare AJ, Scott J, Mitterschiffthaler MT, Walsh ND et al (2008). Neural responses to sad facial expressions in major depression following cognitive behavioral therapy. Biol Psychiatry 64: 505-512.
26. Graff-Guerrero A, Pellicer F, Mendoza-Espinosa Y, Mart́nez-Medina P, Romero-Romo J, de la Fuente Sandoval C (2008). Cerebral blood flow changes associated with experimental pain stimulation in patients with major depression. J Affect Disord 107: 161-168.
27. Greicius MD, Flores BH, Menon V, Glover GH, Solvason HB, Kenna H et al (2007). Resting-state functional connectivity in major depression: abnormally increased contributions from subgenual cingulate cortex and thalamus. Biol Psychiatry 62: 429-437.
28. Grimm S, Boesiger P, Beck J, Schuepbach D, Bermpohl F, Walter M et al (2009). Altered negative BOLD responses in the default-mode network during emotion processing in depressed subjects. Neuropsychopharmacology 34: 932-943.
29. Gupta S, Nihalani N, Masand P (2007). Duloxetine: review of its pharmacology, and therapeutic use in depression and other psychiatric disorders. Ann Clin Psychiatry 19: 125-132.
30. Guy W (ed) (1976). Clinical Global Impressions. In: ECDEU Assessment Manual for Psychopharmacology, Revised (DHEW Publication No ADM 76-338). National Institute of Mental Health: Rockville, MD. pp 218-222.
31. Hamilton M (1960). A rating scale for depression. J Neurol Neurosurg Psychiatry 23: 56-62.
32. Hamilton M (1967). The development of a scale for primary depressive illness. Br J Soc Clin Psychol 6: 278-296.
33. Harrison BJ, Pujol J, López-Solà M, Hernández-Ribas R, Deus J, Ortiz H et al (2008). Consistency and functional specialization in the default mode brain network. Proc Natl Acad Sci USA 105: 9781-9786.
34. Hirschfeld RM, Mallinckrodt C, Lee TC, Detke MJ (2005). Time course of depression-symptom improvement during treatment with duloxetine. Depress Anxiety 21: 170-177.
35. Hofbauer RK, Rainville P, Duncan GH, Bushnell MC (2001). Cortical representation of the sensory dimension of pain. J Neurophysiol 86: 402-411.
36. Jochum T, Boettger MK, Wigger A, Beiderbeck D, Neumann ID, Landgraf R et al (2007). Decreased sensitivity to thermal pain in rats bred for high anxiety-related behaviour is attenuated by citalopram or diazepam treatment. Behav Brain Res 183: 18-24.
37. Keedwell PA, Drapier D, Surguladze S, Giampietro V, Brammer M, Phillips M (2010). Subgenual cingulate and visual cortex responses to sad faces predict clinical outcome during anti-depressant treatment for depression. J Affect Disord 120: 120-125.
38. Kellner R (1987). A symptom questionnaire. J Clin Psychiatry 48: 268-274.
39. Lautenbacher S, Roscher S, Strian D, Fassbender K, Krumrey K, Krieg JC (1994). Pain perception in depression: relationships to symptomatology and naloxone-sensitive mechanisms. Psycho-som Med 56: 345-352.
40. Lautenbacher S, Spernal J, Schreiber W, Krieg JC (1999). Relationship between clinical pain complaints and pain sensitivity in patients with depression and panic disorder. Psychosom Med 61: 822-827.
41. Lieberman MD, Cunningham WA (2009). Type I and type II error concerns in fMRI research: re-balancing the scale. Soc Cogn Affect Neurosci 4: 423-428.
42. Lieberman MD, Jarcho JM, Berman S, Naliboff BD, Suyenobu BY, Mandelkern M et al (2004). The neural correlates of placebo effects: a disruption account. Neuroimage 22: 447-455.
43. Liotti M, Mayberg HS (2001). The role of functional neuroimaging in the neuropsychology of depression. J Clin Exp Neuropsychol 23: 121-136.
44. Little JT, Ketter TA, Kimbrell TA, Dunn RT, Benson BE, Willis MW et al (2005). Bupropion and venlafaxine responders differ in pretreatment regional cerebral metabolism in unipolar depression. Biol Psychiatry 57: 220-228.
45. López-Solà M, Pujol J, Hernández-Ribas R, Harrison BJ, Ortiz H, Soriano-Mas C et al (2010). Dynamic assessment of the right lateral frontal cortex response to painful stimulation. Neuro-image 50: 1177-1187.
46. Lorenz J, Minoshima S, Casey KL (2003). Keeping pain out of mind: the role of the dorsolateral prefrontal cortex in pain modulation. Brain 126: 1079-1091.
47. Matthews S, Simmons A, Strigo I, Gianaros P, Yang T, Paulus M (2009). Inhibition-related activity in subgenual cingulate is associated with symptom severity in major depression. Psychiatry Res 172: 1-6.
48. Mayberg HS (2003). Positron emission tomography imaging in depression: a neural systems perspective. Neuroimaging Clin N Am 13: 805-815.
49. Mayberg HS (2009). Targeted electrode-based modulation of neural circuits for depression. J Clin Invest 119: 717-725.
50. Mayberg HS, Brannan SK, Mahurin RK, Jerabek PA, Brickman JS, Tekell JL et al (1997). Cingulate function in depression: a potential predictor of treatment response. Neuroreport 8: 1057-1061.
51. Mayberg HS, Brannan SK, Tekell JL, Silva JA, Mahurin RK, McGinnis S et al (2000). Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response. Biol Psychiatry 48: 830-843.
52. Mayberg HS, Lozano AM, Voon V, McNeely HE, Seminowicz D, Hamani C et al (2005). Deep brain stimulation for treatment-resistant depression. Neuron 45: 651-660.
53. Mayberg HS, Silva JA, Brannan SK, Tekell JL, Mahurin RK, McGinnis S et al (2002). The functional neuroanatomy of the placebo effect. Am J Psychiatry 159: 728-737.
54. Milak MS, Parsey RV, Lee L, Oquendo MA, Olvet DM, Eipper F et al (2009). Pretreatment regional brain glucose uptake in the midbrain on PET may predict remission from a major depressive episode after three months of treatment. Psychiatry Res 173: 63-70.
55. Mitterschiffthaler MT, Williams SC, Walsh ND, Cleare AJ, Donaldson C, Scott J et al (2008). Neural basis of the emotional Stroop interference effect in major depression. Psychol Med 38: 247-256.
56. Mottaghy FM, Keller CE, Gangitano M, Ly J, Thall M, Parker JA et al (2002). Correlation of cerebral blood flow and treatment effects of repetitive transcranial magnetic stimulation in depressed patients. Psychiatry Res 115: 1-14.
57. Moulton EA, Keaser ML, Gullapalli RP, Greenspan JD (2005). Regional intensive and temporal patterns of functional MRI activation distinguishing noxious and innocuous contact heat. J Neurophysiol 93: 2183-2193.
58. Nahas Z, Teneback C, Chae JH, Mu Q, Molnar C, Kozel FA et al. (2007). Serial vagus nerve stimulation functional MRI in treatment resistant depression. Neuropsychopharmacology 32: 1649-1660. (Pubitemid 47076372)
59. Nemeroff CB, Schatzberg AF, Goldstein DJ, Detke MJ, Mallinckrodt C, Lu Y et al (2002). Duloxetine for the treatment of major depressive disorder. Psychopharmacol Bull 36: 106-132.
60. Padberg F, George MS (2009). Repetitive transcranial magnetic stimulation of the prefrontal cortex in depression. Exp Neurol 219: 2-13.
61. Paus T (2001). Primate anterior cingulate cortex: where motor control, drive and cognition interface. Nat Rev Neurosci 2: 417-424.
62. Petrovic P, Petersson KM, Ghatan PH, Stone-Elander S, Ingvar M (2000). Pain-related cerebral activation is altered by a distracting cognitive task. Pain 85: 19-30.
63. Peyron R, Garća-Larrea L, Grégoire MC, Costes N, Convers P, Lavenne F et al (1999). Haemodynamic brain responses to acute pain in humans: sensory and attentional networks. Brain 122: 1765-1780.
64. Peyron R, Laurent B, Garća-Larrea L (2000). Functional imaging of brain responses to pain. A review and meta-analysis (2000). Neurophysiol Clin 30: 263-288.
65. Price DD (2000). Psychological and neural mechanisms of the affective dimension of pain. Science 288: 1769-1772.
66. Price JL (1999). Prefrontal cortical networks related to visceral function and mood. Ann NY Acad Sci 877: 383-396.
67. Price JL, Drevets WC (2010). Neurocircuitry of mood disorders. Neuropsychopharmacology 35: 192-216.
68. Pujol J, López-Solà M, Ortiz H, Vilanova JC, Harrison BJ, Yücel M et al (2009). Mapping brain response to pain in fibromyalgia patients using temporal analysis of FMRI. PLoS One 4: e5224.
69. Raichle ME, MacLeod AM, Snyder AZ, Powers WJ, Gusnard DA, Shulman GL (2001). A default mode of brain function. Proc Natl Acad Sci USA 98: 676-682.
70. Rainville P, Duncan GH, Price DD, Carrier B, Bushnell MC (1997). Pain affect encoded in human anterior cingulate but not somatosensory cortex. Science 277: 968-971.
71. Regier DA, Myers JK, Kramer M, Robins LN, Blazer DG, Hough RL et al (1984). The NIMH Epidemiologic Catchment Area program. Historical context, major objectives, and study population characteristics. Arch Gen Psychiatry 41: 934-941.
72. Ressler KJ, Mayberg HS (2007). Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic. Nat Neurosci 10: 1116-1124.
73. Rigucci S, Serafini G, Pompili M, Kotzalidis GD, Tatarelli R (2009). Anatomical and functional correlates in major depressive disorder: the contribution of neuroimaging studies. World J Biol Psychiatry 9: 1-16.
74. Robertson B, Wang L, Diaz MT, Aiello M, Gersing K, Beyer J et al (2007). Effect of bupropion extended release on negative emotion processing in major depressive disorder: a pilot functional magnetic resonance imaging study. J Clin Psychiatry 68: 261-267.
75. Roffman JL, Marci CD, Glick DM, Dougherty DD, Rauch SL (2005). Neuroimaging and the functional neuroanatomy of psychotherapy. Psychol Med 35: 1385-1398.
76. Salomons TV, Johnstone T, Backonja MM, Davidson RJ (2004). Perceived controllability modulates the neural response to pain. J Neurosci 24: 7199-7203.
77. Salomons TV, Johnstone T, Backonja MM, Shackman AJ, Davidson RJ (2007). Individual differences in the effects of perceived controllability on pain perception: critical role of the prefrontal cortex. J Cogn Neurosci 19: 993-1003.
78. Saxena S, Brody AL, Ho ML, Zohrabi N, Maidment KM, Baxter LR (2003). Differential brain metabolic predictors of response to paroxetine in obsessive-compulsive disorder versus major depression. Am J Psychiatry 160: 522-532.
79. Schmahl C, Bohus M, Esposito F, Treede RD, Di Salle F, Greffrath W et al (2006). Neural correlates of antinociception in borderline personality disorder. Arch Gen Psychiatry 63: 659-667. (Pubitemid 43848297)
80. Schmidt EZ, Reininghaus B, Enzinger C, Ebner C, Hofmann P, Kapfhammer HP (2008). Changes in brain metabolism after ECT-positron emission tomography in the assessment of changes in glucose metabolism subsequent to electroconvulsive therapyFlessons, limitations and future applications. J Affect Disord 106: 203-208.
81. Sheline YI (2003). Neuroimaging studies of mood disorder effects on the brain. Biol Psychiatry 54: 338-352.
82. Sheline YI, Barch DM, Donnelly JM, Ollinger JM, Snyder AZ, Mintun MA (2001). Increased amygdale response to masked emotional faces in depressed subjects resolves with antidepressant treatment: an fMRI study. Biol Psychiatry 50: 651-658.
83. Sheline YI, Barch DM, Price JL, Rundle MM, Vaishnavi SN, Snyder AZ et al (2009). The default mode network and self-referential processes in depression. Proc Natl Acad Sci USA 106: 1942-1947.
84. Shelton RC, Prakash A, Mallinckrodt CH, Wohlreich MM, Raskin J, Robinson MJ et al (2007). Patterns of depressive symptom response in duloxetine-treated outpatients with mild, moderate or more severe depression. Int J Clin Pract 61: 1337-1348.
85. Siegle GJ, Carter CS, Thase ME (2006). Use of FMRI to predict recovery from unipolar depression with cognitive behavior therapy. Am J Psychiatry 163: 735-738.
86. Strigo IA, Simmons AN, Matthews SC, Craig AD, Paulus MP (2008). Association of major depressive disorder with altered functional brain response during anticipation and processing of heat pain. Arch Gen Psychiatry 65: 1275-1284.
87. Trivedi MH, Desaiah D, Ossanna MJ, Pritchett YL, Brannan SK, Detke MJ (2008). Clinical evidence for serotonin and norepi-nephrine reuptake inhibition of duloxetine. Int Clin Psycho-pharmacol 23: 161-169.
88. Vasic N, Walter H, Sambataro F, Wolf RC (2009). Aberrant functional connectivity of dorsolateral prefrontal and cingulate networks in patients with major depression during working memory processing. Psychol Med 39: 977-987.
89. Wager TD, Rilling JK, Smith EE, Sokolik A, Casey KL, Davidson RJ et al (2004). Placebo-induced changes in FMRI in the anticipation and experience of pain. Science 303: 1162-1167.
90. Wagner G, Koch K, Schachtzabel C, Reichenbach JR, Sauer H, Schlösser RG (2008). Enhanced rostral anterior cingulate cortex activation during cognitive control is related to orbitofrontal volume reduction in unipolar depression. J Psychiatry Neurosci 33: 199-208.
91. Wagner G, Sinsel E, Sobanski T, Köhler S, Marinou V, Mentzel HJ et al (2006). Cortical inefficiency in patients with unipolar depression: an event-related FMRI study with the Stroop task. Biol Psychiatry 59: 958-965.
92. Wiech K, Farias M, Kahane G, Shackel N, Tiede W, Tracey I (2008b). An fMRI study measuring analgesia enhanced by religion as a belief system. Pain 139: 467-476.
93. Wiech K, Kalisch R, Weiskopf N, Pleger B, Stephan KE, Dolan RJ (2006). Anterolateral prefrontal cortex mediates the analgesic effect of expected and perceived control over pain. J Neurosci 26: 11501-11509.
94. Wiech K, Ploner M, Tracey I (2008a). Neurocognitive aspects of pain perception. Trends Cogn Sci 12: 306-313.
95. World Health Organization (2001). The world health report. Error! Hyperlink reference not valid.
96. Wu J, Buchsbaum MS, Gillin JC, Tang C, Cadwell S, Wiegand M et al (1999). Prediction of antidepressant effects of sleep deprivation by metabolic rates in the ventral anterior cingulate and medial prefrontal cortex. Am J Psychiatry 156: 1149-1158.